# Did it run end-to-end? If it stalled or errored, where? What did you do? Include the actual error message if relevant.
Yes, eventually it ran from end to end and produced a complete notebook, but this took around 12 trials to compile without any error. The first several attempts were mostly setup and trial-and-error rather than true debugging, because I was still figuring out how the repo expected the command, API key, model name, and execution mode to be configured.
After this I am trying to see if I can actually get the output from the script, as the analysis was finished, but the output was not shown, and it shows: 
  File "/opt/conda/envs/CellVoyager/lib/python3.10/site-packages/nbclient/client.py", line 1009, in async_execute_cell
    raise DeadKernelError("Kernel died") from None
nbclient.exceptions.DeadKernelError: Kernel died


# Code-execution stats. Of the code cells the agent generated, how many executed cleanly on the first try? How many needed fix attempts? Were any unfixable?

During the first 10 trials, the run stopped before a notebook could be outputted. Most of those are setting up issues, especially API key routing, model naming, and repo execution configuration. The last two were ran successfully with the second to last with not as precise model name. The last one was ran with the exact correct model. There are not any unfixable code cell in this run. 
However, during both of the successful runs, there aren't any output in the output folder, and to so what is really happening with the notebook, I decided to manually run the output once to see if I can get something to visualize.  
I could not fully evaluate the LLM’s interpretation of the output because the generated notebook could not be re-executed. Running jupyter nbconvert --execute output_analysis_1.ipynb caused a DeadKernelError: Kernel died. The terminal log only shows the analysis trajectory/plans, not concrete outputs such as plots, p-values, or marker tables.


# Trajectory quality. For each step in the resulting notebook, briefly note: (a) was the hypothesis sensible given the COVID-19 dataset, (b) did the code actually do what the hypothesis described, (c) is the LLM's interpretation of the output reasonable.

In the first step, it tested the inflammatory ligand exoression in monocytes between ventilated and non-ventilated COVID patients, and the hypothesis is sensible to the given dataset and matched the Covid inflammation patter. 
In the second step, it tested ligand-receptor interaction for moncytes and T cells, which is also sensible which it did a vizualization of step 1
In step 3, it is sensible, as in this step it is first comparing the leiden subclustering and the DE genes, and then calcilating the ligand receptor interaction scores between monocytes and T cell, and both of this  are sensible as monocyte heterogeneity and its interaction with immune system is related to COVID
Step 4 is very sensible, as it is focusing on COVID specifically, and it is trying to find biologically meaningful factors. 
I was not able to actually visualize any output to answer b and c. 


# Overlap with the paper. For this dataset the paper highlights findings around CD8+ T cell pyroptosis, monocyte HLA class II downregulation, and plasmablast / developing-neutrophil dynamics. Did your trajectory go anywhere near these directions? If it explored elsewhere, what did it find?
There are a partial overlap between the paper and this trajectory. In the paper it discussed monocyte dysfunction and immune dysregulation through inflammatory signaling and the analysis between monocyte and T cell in step. The other part such as CD8+ HLA class down regulation were not explicitly mentioned. 

# Cost log.
It cost less than 5 cents USD.

# Judegement questions: 
## What surprised you most about getting this running?
What surprised me most was how detail we have to be when running the scripts, the command line structures, it took more time in fine tuning then I thought. Although the scripts were ready to go and make everything easier, but actually running something unfamilar takes more effort than I thought as it requires real understanding for the commands and the scripts, and would encounter many unexpected problems. 
I was also a bit surprised of how low the cost was, which made me a little suspicious if the analysis was done correctly, but with a little running out of time, I wish to dig more into it. 

## Where in the pipeline did you have to make a judgment call that wasn't specified by the paper or repo? What did you decide and why?
I think the part that stands out is the API usage, the paper used OPENAI API and we are using DEEPSEEK, which made a confusion during the setup, although going back it seems a pretty small and straight forward thing, but during the implementation it is still it bit struggling. 
During the implementation I choose to use a different API KEY NAME variable instead of the one given, but it turns out that does not work. This error leads to a lot of larger error such as incorrect LLM name, in which directly solving the error popped up was not solving the problem, and that is the reason it took a while to get the scripts to run before catching the API name error. 
The judgment call I have to make was the output error as I continuously not getting any output seen for the notebook, but the analysis was ran sucessfully. I have to do some research and try different ways to seek for output, but none has succeed right now. 

## The paper grades trajectories via expert biologist review. If you wanted to evaluate this kind of agent without recruiting biologists, what would you do?
I believe comparing publsihed work and published results would be one way. 
I would also test its self-crituqe ability as this is what CellVoyager is emphasizing on, and see how close is its critique comapred to other published results done by biologist. 
I would also run multiple benchmark on it and compare the results. 

## If you had another week, what one experiment would most strengthen or weaken the paper's case-study claim?
- I would like to run the scripts on different models other than deepseekv4 and compare the results
- Run the same dataset and use the same frontier model for different agent we talked about such as CellAgent
- Run on multiple iterations. 
- Test the agent with BixBench and other benchmark

I think comparing the results with different agent and run it on benchmark can strengthen the claim if the results shows benchmark test is good and the results for CellVoyager is better (closer to what human researcher would have) than other agents. 

